Josh Riggs - Oncocyte Corporation’s Chief Executive Officer
PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace
May 07, 2024 09:19 ET | PRISM MarketView
PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace
logo-horizontal-main.png
Oncocyte Reports Full Year 2023 Financial Results
April 12, 2024 06:00 ET | OncoCyte Corporation
ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS
logo-horizontal-main.png
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
April 11, 2024 21:46 ET | OncoCyte Corporation
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
logo-horizontal-main.png
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
April 11, 2024 17:30 ET | OncoCyte Corporation
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
logo-horizontal-main.png
Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results
April 09, 2024 16:05 ET | OncoCyte Corporation
ONCOCYTE TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
logo-horizontal-main.png
Oncocyte to Present at the Sequire Investor Summit in Puerto Rico
January 16, 2024 08:00 ET | OncoCyte Corporation
Oncocyte to Present at the Sequire Investor Summit in Puerto Rico